FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Vet J / Medical treatment of osteoarthritis in the horse – a r...
Veterinary journal (London, England : 1997)2006; 171(1); 51-69; doi: 10.1016/j.tvjl.2004.07.008

Medical treatment of osteoarthritis in the horse – a review.

Abstract: The medical treatment of osteoarthritis (OA) in the horse is one of the most utilized therapeutic regimens in the equine practice. It is important to understand the anatomy of synovial joints and the pathophysiology of the disease process to treat OA adequately. Once a thorough understanding of the disease process is comprehended the proper combination of systemic nonsteroidal anti-inflammatory drugs (NSAIDs), intraarticular steroids, viscosupplementation and chondroprotectants can be used to treat the disease and inhibit further progression of degenerative changes to the cartilage surface. The equine practitioner is faced with many choices for controlling inflammation in OA. This review presents the background and appropriate uses of various NSAIDs such as phenylbutazone, flunixin meglumine, ketoprofen, naproxen, and carprofen as well as their associated toxicities. Various steroid formulations exist for intraarticular (IA) administration and much has been learned in the past decade regarding correct dosage, frequency of administrations, indications and toxicity. This review presents IA steroids and their indications in addition to various chondroprotective drugs that also exist to control inflammation and provide viscosupplementation. Data are also given on disease modifying OA drugs such as glucosamine and chondroitin sulphate that have more recently become available to the equine practitioner.
Get Full Text
Publication Date: 2006-01-24 PubMed ID: 16427582DOI: 10.1016/j.tvjl.2004.07.008Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article discusses the various methods of treating osteoarthritis (OA) in horses, including the use of intraarticular steroids, nonsteroidal anti-inflammatory drugs (NSAIDs), chondroprotective drugs, and disease-modifying drugs such as glucosamine and chondroitin sulphate.

Understanding Osteoarthritis in Horses

  • The study emphasizes the importance of comprehensive understanding of the anatomy of synovial joints, which are most commonly affected by OA, and the ways in which the disease progresses. This understanding lays the foundation for choosing the right treatments.
  • Osteoarthritis is a degenerative disease involving the joints and is typically characterized by inflammation and progressive wearing away of the cartilage surface. Degenerative changes take place over time and timely treatment can help in preventing any further progression.

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

  • The research highlights the use of systemic NSAIDs as a treatment option. These medications help control inflammation and reduce joint pain.
  • The article examines different NSAIDs such as phenylbutazone, flunixin meglumine, ketoprofen, naproxen, and carprofen, discussing their efficacy and the potential toxicities associated with each.

Intraarticular Steroids

  • Intraarticular steroids are drugs that are directly injected into the joint affected by OA to help reduce inflammation and improve joint function.
  • The article reviews various steroid formulations, analyzing their appropriate dosing, administration frequency, and specific indications and potential toxicities.

Chondroprotective Drugs and Viscosupplementation

  • Chondroprotective drugs are highlighted as an integral part of OA treatment. These medications help protect the cartilage from further damage and encourage the production of synovial fluid to improve joint flexibility.
  • Viscosupplementation – the injection of a gel-like substance into a joint to supplement the viscous properties of the natural joint fluid – is explored as a treatment option.

Disease-Modifying Osteoarthritis Drugs

  • The paper also provides an overview on disease-modifying OA drugs like glucosamine and chondroitin sulphate, which have recently become more readily available to equine practitioners. These medications not only help control symptoms but also slow down the progression of the disease.

Cite This Article

APA
Goodrich LR, Nixon AJ. (2006). Medical treatment of osteoarthritis in the horse – a review. Vet J, 171(1), 51-69. https://doi.org/10.1016/j.tvjl.2004.07.008

Publication

Veterinary journal (London, England : 1997)
ISSN: 1090-0233
NlmUniqueID: 9706281
Country: England
Language: English
Volume: 171
Issue: 1
Pages: 51-69

Researcher Affiliations

Goodrich, Laurie R
  • Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853-6401, USA. lrg7@cornell.edu
Nixon, Alan J

    MeSH Terms

    • Animals
    • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
    • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
    • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
    • Cartilage, Articular / drug effects
    • Cartilage, Articular / pathology
    • Glucosamine / therapeutic use
    • Horse Diseases / drug therapy
    • Horse Diseases / pathology
    • Horses
    • Injections, Intra-Articular / veterinary
    • Joint Diseases / drug therapy
    • Joint Diseases / pathology
    • Joint Diseases / veterinary
    • Osteoarthritis / drug therapy
    • Osteoarthritis / pathology
    • Osteoarthritis / veterinary
    • Steroids / administration & dosage
    • Steroids / adverse effects
    • Steroids / therapeutic use
    • Treatment Outcome

    References

    This article includes 173 references

    Citations

    This article has been cited 67 times.
    1. Carmona JU, López C. Platelet-Rich Plasma in Equine Osteoarthritis: A Systematic Review of Clinical and Experimental Evidence. Animals (Basel) 2025 Sep 9;15(18).
      doi: 10.3390/ani15182647pubmed: 41007891google scholar: lookup
    2. Gaesser AM, Cianci JM, Even K, Linardi RL, Ruthel G, Barot D, Elkhenany H, Engiles JB, Ortved KF. Equine Bone Marrow-Derived MSCs and Their EVs Exhibit Different Immunomodulatory Effects on Cartilage Explants in an In Vitro Osteoarthritis Model. Cartilage 2025 Sep 25;:19476035251378693.
      doi: 10.1177/19476035251378693pubmed: 40995888google scholar: lookup
    3. Marcellin-Little DJ, Hulse DA, Huntingford JL, Grubb T, Brunke MW, Markley AP, Frank B. A proposed framework for practical multimodal management of osteoarthritis in growing dogs. Front Vet Sci 2025;12:1565922.
      doi: 10.3389/fvets.2025.1565922pubmed: 40357193google scholar: lookup
    4. Secor EJ, Womack SJ, Ysebaert MP, Colville MJ, Reesink HL. Synovial fluid alpha-2-macroglobulin, gelsolin and lubricin distinguish between osteoarthritic and healthy equine joints. Equine Vet J 2026 Jan;58(1):49-59.
      doi: 10.1111/evj.14511pubmed: 40342270google scholar: lookup
    5. Guidoni K, Chiaradia E, Pepe M, Di Meo A, Tognoloni A, Seccaroni M, Beccati F. The Combined Use of Triamcinolone and Platelet-Rich Plasma in Equine Metacarpophalangeal Joint Osteoarthritis Treatments: An In Vivo and In Vitro Study. Animals (Basel) 2024 Dec 17;14(24).
      doi: 10.3390/ani14243645pubmed: 39765549google scholar: lookup
    6. Costa GL, Tabbì M, Bruschetta G, Spadola F, Leonardi F, Bruno F, Iannelli NM, Licata P, Macrì F, Passino ES, Macrì D, Interlandi C. Analgesic efficacy of tapentadol in chronic joint disorders in horses: plasma serotonin concentration and adrenocortical response as biomarkers of pain-induced stress. Front Vet Sci 2024;11:1505398.
      doi: 10.3389/fvets.2024.1505398pubmed: 39742317google scholar: lookup
    7. Aragona F, Tabbì M, Gugliandolo E, Giannetto C, D'Angelo F, Fazio F, Interlandi C. Role of cannabidiolic acid or the combination of cannabigerol/cannabidiol in pain modulation and welfare improvement in horses with chronic osteoarthritis. Front Vet Sci 2024;11:1496473.
      doi: 10.3389/fvets.2024.1496473pubmed: 39720409google scholar: lookup
    8. Terlinden A, Jacquet S, Manivong S, Cullier A, Cassé F, Legendre F, Garcia AA, Roullin G, Moldovan F, Sirois P, Banquy X, Galéra P, Audigié F, Demoor M, Bertoni L. Double-blinded, randomized tolerance study of a biologically enhanced Nanogel with endothelin-1 and bradykinin receptor antagonist peptides via intra-articular injection for osteoarthritis treatment in horses. BMC Vet Res 2024 Dec 4;20(1):547.
      doi: 10.1186/s12917-024-04352-wpubmed: 39633332google scholar: lookup
    9. Witkowska-Piłaszewicz O, Malin K, Dąbrowska I, Grzędzicka J, Ostaszewski P, Carter C. Immunology of Physical Exercise: Is Equus caballus an Appropriate Animal Model for Human Athletes?. Int J Mol Sci 2024 May 10;25(10).
      doi: 10.3390/ijms25105210pubmed: 38791248google scholar: lookup
    10. Tesena P, Vinijkumthorn R, Preuksathaporn T, Piyakul P, Chotikaprakal T, Sirireugwipas R, Wong-Aree K, Prapaiwan N. Evaluation of gastrointestinal tract lesions and serum malondialdehyde levels after repeated oral administration of phenylbutazone in horses. Vet Res Commun 2024 Aug;48(4):2343-2355.
      doi: 10.1007/s11259-024-10415-ypubmed: 38771448google scholar: lookup
    11. Scantamburlo G, Nofziger C, Paulmichl M, Vanoni S. Genetic analysis of the equine orthologues for human CYP2D6: unraveling the complexity of the CYP2D family in horses. Front Vet Sci 2023;10:1188633.
      doi: 10.3389/fvets.2023.1188633pubmed: 37929279google scholar: lookup
    12. O'Brien TJ, Hollinshead F, Goodrich LR. Extracellular vesicles in the treatment and prevention of osteoarthritis: can horses help us translate this therapy to humans?. Extracell Vesicles Circ Nucl Acids 2023 Jun;4(2):151-169.
      doi: 10.20517/evcna.2023.11pubmed: 37829144google scholar: lookup
    13. Akyol BA, Gokbulut C. The effect of intravenous lipid emulsion (ILE) on the pharmacokinetic/toxicokinetic dispositions of ivermectin and carprofen in rabbits. Naunyn Schmiedebergs Arch Pharmacol 2024 Mar;397(3):1841-1852.
      doi: 10.1007/s00210-023-02738-5pubmed: 37768375google scholar: lookup
    14. Jammes M, Contentin R, Audigié F, Cassé F, Galéra P. Effect of pro-inflammatory cytokine priming and storage temperature of the mesenchymal stromal cell (MSC) secretome on equine articular chondrocytes. Front Bioeng Biotechnol 2023;11:1204737.
      doi: 10.3389/fbioe.2023.1204737pubmed: 37720315google scholar: lookup
    15. Thampi P, Seabaugh KA, Pezzanite LM, Chu CR, Phillips JN, Grieger JC, McIlwraith CW, Samulski RJ, Goodrich LR. A pilot study to determine the optimal dose of scAAVIL-1ra in a large animal model of post-traumatic osteoarthritis. Gene Ther 2023 Dec;30(12):792-800.
      doi: 10.1038/s41434-023-00420-2pubmed: 37696981google scholar: lookup
    16. Palomino Lago E, Jelbert ER, Baird A, Lam PY, Guest DJ. Equine induced pluripotent stem cells are responsive to inflammatory cytokines before and after differentiation into musculoskeletal cell types. In Vitro Cell Dev Biol Anim 2023 Aug;59(7):514-527.
      doi: 10.1007/s11626-023-00800-3pubmed: 37582999google scholar: lookup
    17. Zamith Cunha R, Zannoni A, Salamanca G, De Silva M, Rinnovati R, Gramenzi A, Forni M, Chiocchetti R. Expression of cannabinoid (CB1 and CB2) and cannabinoid-related receptors (TRPV1, GPR55, and PPARα) in the synovial membrane of the horse metacarpophalangeal joint. Front Vet Sci 2023;10:1045030.
      doi: 10.3389/fvets.2023.1045030pubmed: 36937015google scholar: lookup
    18. Mayet A, Zablotski Y, Roth SP, Brehm W, Troillet A. Systematic review and meta-analysis of positive long-term effects after intra-articular administration of orthobiologic therapeutics in horses with naturally occurring osteoarthritis. Front Vet Sci 2023;10:1125695.
      doi: 10.3389/fvets.2023.1125695pubmed: 36908512google scholar: lookup
    19. Fadel C, Giorgi M. Synopsis of the pharmacokinetics, pharmacodynamics, applications, and safety of firocoxib in horses. Vet Anim Sci 2023 Mar;19:100286.
      doi: 10.1016/j.vas.2023.100286pubmed: 36684818google scholar: lookup
    20. Taguchi T, Morales Yniguez FJ, Takawira C, Andrews FM, Lopez MJ. Agmatine Administration Effects on Equine Gastric Ulceration and Lameness. J Clin Med 2022 Dec 8;11(24).
      doi: 10.3390/jcm11247283pubmed: 36555900google scholar: lookup
    21. Thampi P, Samulski RJ, Grieger JC, Phillips JN, McIlwraith CW, Goodrich LR. Gene therapy approaches for equine osteoarthritis. Front Vet Sci 2022;9:962898.
      doi: 10.3389/fvets.2022.962898pubmed: 36246316google scholar: lookup
    22. Jain S, Patil SG, Chinta G, Alluri KV. TamaFlex™-A novel nutraceutical blend improves lameness and joint functions in working horses. Vet Med Sci 2022 Sep;8(5):1936-1945.
      doi: 10.1002/vms3.894pubmed: 35905197google scholar: lookup
    23. Baccarin RYA, Seidel SRT, Michelacci YM, Tokawa PKA, Oliveira TM. Osteoarthritis: a common disease that should be avoided in the athletic horse's life. Anim Front 2022 Jun;12(3):25-36.
      doi: 10.1093/af/vfac026pubmed: 35711506google scholar: lookup
    24. Estrada McDermott J, Pezzanite L, Goodrich L, Santangelo K, Chow L, Dow S, Wheat W. Role of Innate Immunity in Initiation and Progression of Osteoarthritis, with Emphasis on Horses. Animals (Basel) 2021 Nov 13;11(11).
      doi: 10.3390/ani11113247pubmed: 34827979google scholar: lookup
    25. Ziegler AL, Blikslager AT. Sparing the gut: COX-2 inhibitors herald a new era for treatment of horses with surgical colic. Equine Vet Educ 2020 Nov;32(11):611-616.
      doi: 10.1111/eve.13189pubmed: 34305336google scholar: lookup
    26. Watkins A, Fasanello D, Stefanovski D, Schurer S, Caracappa K, D'Agostino A, Costello E, Freer H, Rollins A, Read C, Su J, Colville M, Paszek M, Wagner B, Reesink H. Investigation of synovial fluid lubricants and inflammatory cytokines in the horse: a comparison of recombinant equine interleukin 1 beta-induced synovitis and joint lavage models. BMC Vet Res 2021 May 12;17(1):189.
      doi: 10.1186/s12917-021-02873-2pubmed: 33980227google scholar: lookup
    27. Ribitsch I, Oreff GL, Jenner F. Regenerative Medicine for Equine Musculoskeletal Diseases. Animals (Basel) 2021 Jan 19;11(1).
      doi: 10.3390/ani11010234pubmed: 33477808google scholar: lookup
    28. Castanheira C, Balaskas P, Falls C, Ashraf-Kharaz Y, Clegg P, Burke K, Fang Y, Dyer P, Welting TJM, Peffers MJ. Equine synovial fluid small non-coding RNA signatures in early osteoarthritis. BMC Vet Res 2021 Jan 9;17(1):26.
      doi: 10.1186/s12917-020-02707-7pubmed: 33422071google scholar: lookup
    29. Copp ME, Flanders MC, Gagliardi R, Gilbertie JM, Sessions GA, Chubinskaya S, Loeser RF, Schnabel LV, Diekman BO. The combination of mitogenic stimulation and DNA damage induces chondrocyte senescence. Osteoarthritis Cartilage 2021 Mar;29(3):402-412.
      doi: 10.1016/j.joca.2020.11.004pubmed: 33227437google scholar: lookup
    30. Bukowska J, Szóstek-Mioduchowska AZ, Kopcewicz M, Walendzik K, Machcińska S, Gawrońska-Kozak B. Adipose-Derived Stromal/Stem Cells from Large Animal Models: from Basic to Applied Science. Stem Cell Rev Rep 2021 Jun;17(3):719-738.
      doi: 10.1007/s12015-020-10049-ypubmed: 33025392google scholar: lookup
    31. Balaskas P, Green JA, Haqqi TM, Dyer P, Kharaz YA, Fang Y, Liu X, Welting TJM, Peffers MJ. Small Non-Coding RNAome of Ageing Chondrocytes. Int J Mol Sci 2020 Aug 7;21(16).
      doi: 10.3390/ijms21165675pubmed: 32784773google scholar: lookup
    32. Nganvongpanit K, Euppayo T, Siengdee P, Buddhachat K, Chomdej S, Ongchai S. Post-treatment of hyaluronan to decrease the apoptotic effects of carprofen in canine articular chondrocyte culture. PeerJ 2020;8:e8355.
      doi: 10.7717/peerj.8355pubmed: 32030322google scholar: lookup
    33. Neuenschwander HM, Moreira JJ, Vendruscolo CP, Fülber J, Seidel SRT, Michelacci YM, Baccarin RYA. Hyaluronic acid has chondroprotective and joint-preserving effects on LPS-induced synovitis in horses. J Vet Sci 2019 Nov;20(6):e67.
      doi: 10.4142/jvs.2019.20.e67pubmed: 31775194google scholar: lookup
    34. Stack JD, Cousty M, Steele E, Handel I, Lechartier A, Vinardell T, David F. Comparison of Serum Amyloid A Measurements in Equine Synovial Fluid With Routine Diagnostic Methods to Detect Synovial Infection in a Clinical Environment. Front Vet Sci 2019;6:325.
      doi: 10.3389/fvets.2019.00325pubmed: 31632987google scholar: lookup
    35. Battaglia B, Angelone M, Vera E, Basini G, Bussolati S, Paci M, Bue MD, Aldigeri R, Grolli S, Quintavalla F, Ramoni R. Clinical Effects of the Extract of the Seeds of the Indian Celery-Apium Graveolens-In Horses Affected by Chronic Osteoarthritis. Animals (Basel) 2019 Aug 20;9(8).
      doi: 10.3390/ani9080585pubmed: 31434330google scholar: lookup
    36. Beaulieu A, Linden AZ, Phillips J, Arroyo LG, Koenig J, Monteith G. Various 3D printed materials mimic bone ultrasonographically: 3D printed models of the equine cervical articular process joints as a simulator for ultrasound guided intra-articular injections. PLoS One 2019;14(8):e0220332.
      doi: 10.1371/journal.pone.0220332pubmed: 31386687google scholar: lookup
    37. Bertoni L, Branly T, Jacquet S, Desancé M, Desquilbet L, Rivory P, Hartmann DJ, Denoix JM, Audigié F, Galéra P, Demoor M. Intra-Articular Injection of 2 Different Dosages of Autologous and Allogeneic Bone Marrow- and Umbilical Cord-Derived Mesenchymal Stem Cells Triggers a Variable Inflammatory Response of the Fetlock Joint on 12 Sound Experimental Horses. Stem Cells Int 2019;2019:9431894.
      doi: 10.1155/2019/9431894pubmed: 31191689google scholar: lookup
    38. Niemelä TM, Tulamo RM, Carmona JU, López C. Evaluation of the effect of experimentally induced cartilage defect and intra-articular hyaluronan on synovial fluid biomarkers in intercarpal joints of horses. Acta Vet Scand 2019 May 30;61(1):24.
      doi: 10.1186/s13028-019-0460-6pubmed: 31146775google scholar: lookup
    39. Broeckx SY, Martens AM, Bertone AL, Van Brantegem L, Duchateau L, Van Hecke L, Dumoulin M, Oosterlinck M, Chiers K, Hussein H, Pille F, Spaas JH. The use of equine chondrogenic-induced mesenchymal stem cells as a treatment for osteoarthritis: A randomised, double-blinded, placebo-controlled proof-of-concept study. Equine Vet J 2019 Nov;51(6):787-794.
      doi: 10.1111/evj.13089pubmed: 30815897google scholar: lookup
    40. Broeckx SY, Seys B, Suls M, Vandenberghe A, Mariën T, Adriaensen E, Declercq J, Van Hecke L, Braun G, Hellmann K, Spaas JH. Equine Allogeneic Chondrogenic Induced Mesenchymal Stem Cells Are an Effective Treatment for Degenerative Joint Disease in Horses. Stem Cells Dev 2019 Mar 15;28(6):410-422.
      doi: 10.1089/scd.2018.0061pubmed: 30623737google scholar: lookup
    41. Hunt CL, Leatherwood JL, Coverdale JA, Sigler DL, Vogelsang MM, Arnold CE. Effects of repeated arthrocentesis on systemic cytokine expression and leukocyte population in young horses challenged with intra-articular lipopolysaccharide. J Anim Sci 2019 Jan 1;97(1):184-191.
      doi: 10.1093/jas/sky423pubmed: 30423145google scholar: lookup
    42. Watson Levings RS, Broome TA, Smith AD, Rice BL, Gibbs EP, Myara DA, Hyddmark EV, Nasri E, Zarezadeh A, Levings PP, Lu Y, White ME, Dacanay EA, Foremny GB, Evans CH, Morton AJ, Winter M, Dark MJ, Nickerson DM, Colahan PT, Ghivizzani SC. Gene Therapy for Osteoarthritis: Pharmacokinetics of Intra-Articular Self-Complementary Adeno-Associated Virus Interleukin-1 Receptor Antagonist Delivery in an Equine Model. Hum Gene Ther Clin Dev 2018 Jun;29(2):90-100.
      doi: 10.1089/humc.2017.142pubmed: 29869540google scholar: lookup
    43. Watson Levings RS, Smith AD, Broome TA, Rice BL, Gibbs EP, Myara DA, Hyddmark EV, Nasri E, Zarezadeh A, Levings PP, Lu Y, White ME, Dacanay EA, Foremny GB, Evans CH, Morton AJ, Winter M, Dark MJ, Nickerson DM, Colahan PT, Ghivizzani SC. Self-Complementary Adeno-Associated Virus-Mediated Interleukin-1 Receptor Antagonist Gene Delivery for the Treatment of Osteoarthritis: Test of Efficacy in an Equine Model. Hum Gene Ther Clin Dev 2018 Jun;29(2):101-112.
      doi: 10.1089/humc.2017.143pubmed: 29869535google scholar: lookup
    44. Barboni B, Russo V, Berardinelli P, Mauro A, Valbonetti L, Sanyal H, Canciello A, Greco L, Muttini A, Gatta V, Stuppia L, Mattioli M. Placental Stem Cells from Domestic Animals: Translational Potential and Clinical Relevance. Cell Transplant 2018 Jan;27(1):93-116.
      doi: 10.1177/0963689717724797pubmed: 29562773google scholar: lookup
    45. Ziegler A, Fogle C, Blikslager A. Update on the use of cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs in horses. J Am Vet Med Assoc 2017 Jun 1;250(11):1271-1274.
      doi: 10.2460/javma.250.11.1271pubmed: 28509650google scholar: lookup
    46. Thomsen LN, Thomsen PD, Downing A, Talbot R, Berg LC. FOXO1, PXK, PYCARD and SAMD9L are differentially expressed by fibroblast-like cells in equine synovial membrane compared to joint capsule. BMC Vet Res 2017 Apr 14;13(1):106.
      doi: 10.1186/s12917-017-1003-xpubmed: 28410619google scholar: lookup
    47. Zayed M, Caniglia C, Misk N, Dhar MS. Donor-Matched Comparison of Chondrogenic Potential of Equine Bone Marrow- and Synovial Fluid-Derived Mesenchymal Stem Cells: Implications for Cartilage Tissue Regeneration. Front Vet Sci 2016;3:121.
      doi: 10.3389/fvets.2016.00121pubmed: 28149840google scholar: lookup
    48. Bembo F, Eraud J, Philandrianos C, Bertrand B, Silvestre A, Veran J, Sabatier F, Magalon G, Magalon J. Combined use of platelet rich plasma & micro-fat in sport and race horses with degenerative joint disease: preliminary clinical study in eight horses. Muscles Ligaments Tendons J 2016 Apr-Jun;6(2):198-204.
      doi: 10.11138/mltj/2016.6.2.198pubmed: 27900293google scholar: lookup
    49. Maumus M, Roussignol G, Toupet K, Penarier G, Bentz I, Teixeira S, Oustric D, Jung M, Lepage O, Steinberg R, Jorgensen C, Noel D. Utility of a Mouse Model of Osteoarthritis to Demonstrate Cartilage Protection by IFNγ-Primed Equine Mesenchymal Stem Cells. Front Immunol 2016;7:392.
      doi: 10.3389/fimmu.2016.00392pubmed: 27729913google scholar: lookup
    50. Tangyuenyong S, Viriyakhasem N, Peansukmanee S, Kongtawelert P, Ongchai S. Andrographolide Exerts Chondroprotective Activity in Equine Cartilage Explant and Suppresses Interleukin-1 β -Induced MMP-2 Expression in Equine Chondrocyte Culture. Int Sch Res Notices 2014;2014:464136.
      doi: 10.1155/2014/464136pubmed: 27379277google scholar: lookup
    51. Barrachina L, Remacha AR, Romero A, Vázquez FJ, Albareda J, Prades M, Ranera B, Zaragoza P, Martín-Burriel I, Rodellar C. Inflammation affects the viability and plasticity of equine mesenchymal stem cells: possible implications in intra-articular treatments. J Vet Sci 2017 Mar 30;18(1):39-49.
      doi: 10.4142/jvs.2017.18.1.39pubmed: 27297420google scholar: lookup
    52. Radi AE, Abd El-Ghany N, Wahdan T. Voltammetric Determination of Flunixin on Molecularly Imprinted Polypyrrole Modified Glassy Carbon Electrode. J Anal Methods Chem 2016;2016:5296582.
      doi: 10.1155/2016/5296582pubmed: 27242945google scholar: lookup
    53. Mirza MH, Bommala P, Richbourg HA, Rademacher N, Kearney MT, Lopez MJ. Gait Changes Vary among Horses with Naturally Occurring Osteoarthritis Following Intra-articular Administration of Autologous Platelet-Rich Plasma. Front Vet Sci 2016;3:29.
      doi: 10.3389/fvets.2016.00029pubmed: 27148544google scholar: lookup
    54. Peffers MJ, Thornton DJ, Clegg PD. Characterization of neopeptides in equine articular cartilage degradation. J Orthop Res 2016 Jan;34(1):106-20.
      doi: 10.1002/jor.22963pubmed: 26124002google scholar: lookup
    55. Ríos DL, López C, Carmona JU. Platelet-Rich Gel Supernatants Stimulate the Release of Anti-Inflammatory Proteins on Culture Media of Normal Equine Synovial Membrane Explants. Vet Med Int 2015;2015:547052.
      doi: 10.1155/2015/547052pubmed: 26090267google scholar: lookup
    56. Peffers MJ, McDermott B, Clegg PD, Riggs CM. Comprehensive protein profiling of synovial fluid in osteoarthritis following protein equalization. Osteoarthritis Cartilage 2015 Jul;23(7):1204-13.
      doi: 10.1016/j.joca.2015.03.019pubmed: 25819577google scholar: lookup
    57. Santangelo KS, Kaeding AC, Baker SA, Bertone AL. Quantitative Gait Analysis Detects Significant Differences in Movement between Osteoarthritic and Nonosteoarthritic Guinea Pig Strains before and after Treatment with Flunixin Meglumine. Arthritis 2014;2014:503519.
      doi: 10.1155/2014/503519pubmed: 24963402google scholar: lookup
    58. Peffers MJ, Cillero-Pastor B, Eijkel GB, Clegg PD, Heeren RM. Matrix assisted laser desorption ionization mass spectrometry imaging identifies markers of ageing and osteoarthritic cartilage. Arthritis Res Ther 2014 May 9;16(3):R110.
      doi: 10.1186/ar4560pubmed: 24886698google scholar: lookup
    59. Amaniti EM, Diakakis N, Patsikas M, Savvas I. Conservative management of a distal epiphyseal metacarpal fracture in a skyros pony. J Equine Sci 2008;19(3):57-61.
      doi: 10.1294/jes.19.57pubmed: 24833956google scholar: lookup
    60. Broeckx S, Zimmerman M, Crocetti S, Suls M, Mariën T, Ferguson SJ, Chiers K, Duchateau L, Franco-Obregón A, Wuertz K, Spaas JH. Regenerative therapies for equine degenerative joint disease: a preliminary study. PLoS One 2014;9(1):e85917.
      doi: 10.1371/journal.pone.0085917pubmed: 24465787google scholar: lookup
    61. Rhee MS, Wei L, Sawhney N, Rice JD, St John FJ, Hurlbert JC, Preston JF. Engineering the xylan utilization system in Bacillus subtilis for production of acidic Xylooligosaccharides. Appl Environ Microbiol 2014 Feb;80(3):917-27.
      doi: 10.1128/AEM.03246-13pubmed: 24271172google scholar: lookup
    62. Peffers M, Liu X, Clegg P. Transcriptomic signatures in cartilage ageing. Arthritis Res Ther 2013 Aug 23;15(4):R98.
      doi: 10.1186/ar4278pubmed: 23971731google scholar: lookup
    63. McIlwraith CW, Frisbie DD, Kawcak CE. The horse as a model of naturally occurring osteoarthritis. Bone Joint Res 2012 Nov;1(11):297-309.
      doi: 10.1302/2046-3758.111.2000132pubmed: 23610661google scholar: lookup
    64. Watson RS, Broome TA, Levings PP, Rice BL, Kay JD, Smith AD, Gouze E, Gouze JN, Dacanay EA, Hauswirth WW, Nickerson DM, Dark MJ, Colahan PT, Ghivizzani SC. scAAV-mediated gene transfer of interleukin-1-receptor antagonist to synovium and articular cartilage in large mammalian joints. Gene Ther 2013 Jun;20(6):670-7.
      doi: 10.1038/gt.2012.81pubmed: 23151520google scholar: lookup
    65. Osaki T, Azuma K, Kurozumi S, Takamori Y, Tsuka T, Imagawa T, Okamoto Y, Minami S. Metabolomic analyses of blood plasma after oral administration of D-glucosamine hydrochloride to dogs. Mar Drugs 2012 Aug;10(8):1873-1882.
      doi: 10.3390/md10081873pubmed: 23015778google scholar: lookup
    66. Azuma K, Osaki T, Tsuka T, Imagawa T, Okamoto Y, Takamori Y, Minami S. Effects of oral glucosamine hydrochloride administration on plasma free amino acid concentrations in dogs. Mar Drugs 2011;9(5):712-718.
      doi: 10.3390/md9050712pubmed: 21673884google scholar: lookup
    67. Villasante A, Araneda OF, Behn C, Galleguillos M, Adarmes H. Antioxidant capacity and oxidative damage determination in synovial fluid of chronically damaged equine metacarpophalangeal joint. Vet Res Commun 2010 Feb;34(2):133-41.
      doi: 10.1007/s11259-009-9338-9pubmed: 20012721google scholar: lookup
    Subscribe to our newsletter
    Join 99,359 horse owners like you who receive our email updates on horse health and nutrition.